Published in Atherosclerosis on January 01, 2001
Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis (2006) 1.42
S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A (2004) 1.32
One-carbon metabolism nutrient status and plasma S-adenosylmethionine concentrations in middle-aged and older Chinese in Singapore. Int J Mol Epidemiol Genet (2012) 0.96
S-adenosyl-L-homocysteine hydrolase and methylation disorders: yeast as a model system. Biochim Biophys Acta (2012) 0.87
Plasma S-adenosylmethionine, DNMT polymorphisms, and peripheral blood LINE-1 methylation among healthy Chinese adults in Singapore. BMC Cancer (2013) 0.83
Regulation of S-adenosylhomocysteine hydrolase by lysine acetylation. J Biol Chem (2014) 0.82
Notable epigenetic role of hyperhomocysteinemia in atherogenesis. Lipids Health Dis (2014) 0.82
A disrupted transsulphuration pathway results in accumulation of redox metabolites and induction of gametocytogenesis in malaria. Sci Rep (2017) 0.75
Mammalian TOR: a homeostatic ATP sensor. Science (2001) 6.41
Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med (1991) 6.03
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation (1995) 4.59
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med (2008) 3.49
Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect (1999) 3.07
Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med (1985) 2.49
Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med (1996) 2.38
Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry (1989) 2.29
A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions. Clin Pharmacol Ther (2013) 2.15
The Pearson product-moment correlation coefficient is better suited for identification of DNA fingerprint profiles than band matching algorithms. Electrophoresis (1993) 1.97
The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. Pediatrics (1997) 1.86
Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy (2010) 1.75
Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med (2004) 1.68
Exercise for intermittent claudication. Cochrane Database Syst Rev (2000) 1.66
Five patients with a biotin-responsive defect in holocarboxylase formation: evaluation of responsiveness to biotin therapy in vivo and comparative biochemical studies in vitro. Pediatr Res (1997) 1.53
[Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany]. Dtsch Med Wochenschr (2008) 1.43
Respiratory distress syndrome. J Am Acad Audiol (1994) 1.40
Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid. Int J Clin Pharmacol Ther (2007) 1.38
Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet (1995) 1.35
Homocystinuria. Evidence for three distinct classes of cystathionine beta-synthase mutants in cultured fibroblasts. J Clin Invest (1978) 1.35
Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothorax. Arch Surg (1991) 1.33
Purification and properties of cystathionine beta-synthase from human liver. Evidence for identical subunits. J Biol Chem (1978) 1.30
Patient-specific electronic decision support reduces prescription of excessive doses. Qual Saf Health Care (2010) 1.28
The Perception of Teasing Scale (POTS): a revision and extension of the Physical Appearance Related Teasing Scale (PARTS). J Pers Assess (1995) 1.28
A versatile incident illuminator for intravital microscopy. Int J Microcirc Clin Exp (1987) 1.27
Measurement of mesenteric blood flow by duplex scanning. J Vasc Surg (1986) 1.24
Lymphoproliferations in the bone marrow: identification and evolution, classification and staging. J Clin Pathol (1984) 1.24
Detection of heterozygotes for homocystinuria. Study of sulphur-containing amino acids in plasma and urine after L-methionine loading. Arch Dis Child (1974) 1.21
Mechanical properties of abdominal aortic aneurysm wall. J Med Eng Technol (2001) 1.20
In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng (2001) 1.20
Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients. Clin Pharmacol Ther (2010) 1.19
Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet (1985) 1.17
A prospective community survey for aminoacidaemias. Proc R Soc Med (1968) 1.16
The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol (2006) 1.16
Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor. J Clin Invest (1998) 1.16
Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis. Clin Pharmacol Ther (2011) 1.15
Defects in human methionine synthase in cblG patients. Hum Mol Genet (1996) 1.15
Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med (2001) 1.15
A late Eemian aridity pulse in central Europe during the last glacial inception. Nature (2005) 1.12
Fluorescence microlymphography. Circulation (1981) 1.11
The relationship between psychological factors and sports injuries. Sports Med (1988) 1.07
Rhabdomyolysis due to interaction of simvastatin with mibefradil. Lancet (1998) 1.07
Acute ischaemic colitis in a female long distance runner. Gut (1987) 1.07
RE: Spontaneous abortion in the British semiconductor industry. Am J Ind Med (1999) 1.06
Congenital absence of insulin cells in a neonate with diabetes mellitus and mutase-deficient methylmalonic acidaemia. Diabetologia (1993) 1.05
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir. Clin Pharmacol Ther (2007) 1.05
Cyanobacterial RNA polymerase genes rpoC1 and rpoC2 correspond to rpoC of Escherichia coli. J Bacteriol (1989) 1.05
HcwA, an autolysin, is required for heterocyst maturation in Anabaena sp. strain PCC 7120. J Bacteriol (2001) 1.05
Clinical diagnosis of malaria and the risk of chloroquine self-medication in rural health centres in Burkina Faso. Trop Med Int Health (2008) 1.04
A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Burns (2005) 1.04
High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study. Pharmacogenomics J (2011) 1.04
Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci (1999) 1.03
Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. Hypertension (1997) 1.03
NEEDLY, a Pinus radiata ortholog of FLORICAULA/LEAFY genes, expressed in both reproductive and vegetative meristems. Proc Natl Acad Sci U S A (1998) 1.03
Lead in bone: storage site, exposure source, and target organ. Neurotoxicology (1994) 1.02
Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol (1992) 1.01
Prospective pilot intervention study to prevent medication errors in drugs administered to children by mouth or gastric tube: a programme for nurses, physicians and parents. Qual Saf Health Care (2010) 1.00
Reduced folate transport to the CNS in female Rett patients. Neurology (2003) 1.00
Reversible ageusia associated with losartan. Lancet (1996) 0.99
Inverse correlation between endothelin-1-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol (1997) 0.98
Late-onset holocarboxylase synthetase-deficiency: pre- and post-natal diagnosis and evaluation of effectiveness of antenatal biotin therapy. Eur J Pediatr (1998) 0.98
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect. Clin Infect Dis (2004) 0.97
Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels. Thromb Haemost (1997) 0.96
Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med (1982) 0.96
Metabolism of cadmium, zinc and copper in the rat kidney: the role of metallothionein and other binding sites. Environ Health Perspect (1984) 0.96
Nigral endothelial dysfunction, homocysteine, and Parkinson's disease. Lancet (1999) 0.95
Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters. Biopharm Drug Dispos (2010) 0.95
The semiconductor elements arsenic and indium induce apoptosis in rat thymocytes. Toxicology (1997) 0.94
Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? Nephrol Dial Transplant (1998) 0.94
Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med (1986) 0.93
Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease. Arterioscler Thromb Vasc Biol (1996) 0.93
Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy. Clin Pharmacol Ther (2011) 0.93
A patient with severe type of epimerase deficiency galactosaemia. J Inherit Metab Dis (1988) 0.92
Chronic myeloproliferative disorders (CMPD). Pathol Res Pract (1984) 0.92
Diffusion, pericapillary distribution and clearance of Na-fluorescein in the human nailfold. Pflugers Arch (1979) 0.92
Depolarization of rat locus coeruleus neurons by adenosine 5'-triphosphate. Neuroscience (1992) 0.92
Assessment of the subclavian vein in patients with transvenous pacemaker leads. Pacing Clin Electrophysiol (1998) 0.92
Hyperhomocysteinemia in premature arterial disease: examination of cystathionine beta-synthase alleles at the molecular level. Hum Mol Genet (1995) 0.91
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Arterioscler Thromb Vasc Biol (1997) 0.90
[Information on medications - How do chronically ill patients assess counselling on drugs in general practice?]. Dtsch Med Wochenschr (2009) 0.90
Intestinal phase of superior mesenteric artery blood flow in man. Gut (1992) 0.90
First searchable database for DNA profiles of human cell lines: sequential use of fingerprint techniques for authentication. Cell Mol Biol (Noisy-le-grand) (1999) 0.90
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol (2004) 0.90
Expression of the growth arrest-specific gene 6 (GAS6) in leukemia and lymphoma cell lines. Leuk Res (1999) 0.89
Consanguineous 3-methylcrotonyl-CoA carboxylase deficiency: early-onset necrotizing encephalopathy with lethal outcome. J Inherit Metab Dis (2005) 0.89
Methylmalonic acidemia mimicking diabetic ketoacidosis in an infant. Pediatr Diabetes (2011) 0.89
Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur J Clin Invest (1999) 0.89
Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. Swiss Med Wkly (2001) 0.88
Pressure traps in femoro-popliteal reversed vein grafts. Are valves culprits? J Cardiovasc Surg (Torino) (1999) 0.88
Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity. Clin Pharmacol Ther (2009) 0.88
Functional activity and transmembrane signaling mechanisms after cryopreservation of human internal mammary arteries. J Vasc Surg (1998) 0.88
The Manchester regional screening programme: a 10-year exercise in patient and family care. Br Med J (1979) 0.88
Pap smear screening among urban Southwestern American Indian women. Prev Med (1999) 0.87
Neurokinin-1 receptor antagonist R116301 inhibits substance P-induced venodilation. Clin Pharmacol Ther (1999) 0.87